Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

dual tasking

The Midas Touch

Smart, but small, science can turn old ideas into gold

- PMLiVE

Havas Lynx launch clinical trial recruitment agency

And poaches Langland’s Mark Evans to lead the new offering

- PMLiVE

Orchard surpasses IPO expectations, raising $200m

Funds will progress rare disease portfolio

- PMLiVE

Healthcare prevention plan worthy, but funding an issue

Aims to boost national life expectancy by five years

Novartis day

Novartis: pipeline will generate 60 filings in three years

Swiss giant predicts wave of innovative treatments

- PMLiVE

Symkevi approval in Europe helps Vertex expand CF treatment

The new combination has shown greater efficacy than Orkambi and with fewer side effects

Roche Basel Switzerland

Roche and AbbVie prepare to move Venclexta into first-line CLL

Data shows an extended PFS compared to those on Gazyva plus chlorambucil chemo

- PMLiVE

BCMA in the spotlight as ASH abstracts drop

Updated results from promising CAR-T therapies are expected

- PMLiVE

Brexit: can pharma ‘take back control’ of the narrative?

Four Public Affairs managing director Sarah Jones talks to PME about the risks of Brexit - and how the sector musn't let the long-term issues become obscured

- PMLiVE

Chameleon reveals new leadership line-up

CEO Hobbs steps down and passes reins on to president, US operations

- PMLiVE

Medical cannabis now available on prescription, for some

But it can’t be prescribed for chronic pain

- PMLiVE

Warning ‘at red’ on no deal Brexit medicines chaos

Report says it's already too late to prepare for a no deal scenario

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links